Abstract
Among cytokine families, the tumor necrosis factor (TNF) superfamily stands out as the one that contains several members with cytotoxic activity (1–3). The best characterized is the prototypic member TNF-α, which is cytotoxic to a range of tumor cells, but not to most types of normal cells (1,4). However, there are now known to be around 20 molecularly related members of the TNF superfamily, several of which induce programmed cell death, i.e., apoptosis, in particular types of normal and tumor cells (1–3). The nomenclature for the members of the TNF superfamily was becoming complicated; individual members were given different names, e.g., Fas ligand, CD95 ligand, APO-1 ligand, by the competing research groups involved in their discovery. Recently, a nomenclature committee has adopted and promoted a simplified naming system; each member is designated tumor necrosis factor super family, TNFSF, with a numerical suffix. Thus, for example, TNF-α becomes TNFSF2 and Fas ligand becomes TNFSF6 (see Table 1 for the full list).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Meager, A. (1998) The Molecular Biology of Cytokines. Wiley, Chichester, UK.
Gravestein, L. A. and Borst, J. (1998) Tumour necrosis factor receptor family members in the immune system. Semin. Immunol. 10, 423–434.
Krammer, P.H. (1999) CD95 (APO/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71, 163–210.
Beyaert, R. and Fiers, W. (1998) Tumour necrosis factor and lymphotoxin, in Cytokines (Mire-Sluis, A. and Thorpe, R., eds.), Academic, San Diego and London, pp. 335–360.
Black, R. A., Rauch, C. T., Kozlosky, C. J., et al. (1997) A metalloproteinase disintegrin that releases tumour necrosis factor-a from cells. Nature 385, 729–733.
Moss, M. L., Jin, S-L. C, Milla, M. E., et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour necrosis factor-α. Nature 385, 733–736.
Meager, A., Leung, H., and Woolley, J. (1989) Assays for tumour necrosis factor and related cytokines. J. Immunol. Methods 116, 1–17.
Matthews, N. and Neale, M. L. (1987) Cytotoxicity assays for tumour necrosis factor and lymphotoxin, in Lymphokines and Interferons—A Practical Approach (Clemens, M. J., Morris, A. G., and Gearing, A. J. H., eds.), IRL, Oxford, pp. 221–225.
Beyaert, R. and Fiers, W. (1994) Molecular mechanisms of tumour necrosis factor-induced cytotoxicity: what we do understand and what we do not. FEBS Lett. 340, 9–16.
Wong, G. H. W. and Goeddel, D.V. (1988) Induction of manganous superperoxide dismutase by tumour necrosis factor: possible protective mechanism. Science 242, 941–943.
Kawaguchi, T., Takeyasu, A., Matsunoba, K., et al. (1990) Stimulation of Mn-superoxide dismutase expression by tumour necrosis factor-α: quantitative determination of Mn-SOD protein levels in TNF-resistant and sensitive cells. Biochem. Biophys. Res. Commun. 171, 1378–1386.
Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241–251.
Minn, A. J., Swain, R. E., Ma, A., and Thompson, C. B. (1998) Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv. Immunol. 70, 245–279.
Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355–365.
Schultz-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., and Peter, M.E. (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439–459.
Hopkins-Donaldson, S., Bodmer, J.-L., Boulrloud, K. B., Brognara, C. B., Tschopp, J., and Gross, N. (2000) Loss of caspase-8 expression in highly malignant human neuroblastoma cells with resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 60, 4315–4319.
Burke, F. and Balkwill, F.R. (2000) Measurement of proliferative, cytostatic, and cytolytic activity of cytokines, in Cytokine Cell Biology: A Practical Approach (Balkwill, F. R., ed.), Oxford University Press, Oxford, pp. 1–16.
Meager, A. and Gaines Das, R. E. (1994) Immunological standardisation: International collaborative study of the candidate international standards for human tumour necrosis factor alpha (hTNF-α), human tumour necrosis factor beta (hTNF-β) and murine tumour necrosis factor alpha (mTNF-α). J. Immunol. Methods 170, 1–13.
Kramer, S. M. and Carver, M. E. (1986) Serum-free in vitro bioassay for the detection of tumour necrosis factor. J. Immunol. Methods 93, 201–206.
Espevik, T. and Nissen-Meyer, J. (1986) A highly sensitive cell line, WEHI164 clone 13, for measuring cytotoxic factor/tumour necrosis factor form human monocytes. J. Immunol. Methods 95, 99–105.
Klostergaard, J. (1985) A rapid extremely sensitive quantitative microassay for cytotoxic cytokines. Lymphokine Res. 4, 309–317.
Smith, R. A. and Baglioni, C. (1987) The active form of tumour necrosis factor is a trimer. J. Biol. Chem. 262, 6951–6954.
Niitsu, Y., Watanabe, N., Sone, H., et al. (1988) Analysis of the TNF receptor on KYM cells by binding assay and affinity cross-linking. J. Biol. Response Mod. 7, 276–282.
Meager, A. (1991) A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. J. Immunol. Methods 144, 141–143.
Meager, A. (1999) A tumour necrosis factor-alpha (TNF-α) sensitive adherent KYM-1D4 derived cell line: use in TNF-α cytotoxicity assays in the presence of actinomycin D. J. Immunol. Methods 227, 197–198.
Caron, G., Delneste, Y., Aubry, J.-P., et al. (1999) Human NK cells constitutively express transmembrane TNFα: a functional role in NK cell-mediated cytotoxicity. Eur. J. Immunol. 29, 3588–3595.
Dirks, W., Schone, S., Uphoff, C. Quentmeier, H., Pradella, S., and Drexler, H. G. (1997) Expression and function of CD95 (FAS/APO-1) in leukaemia lymphoma tumour lines. Br. J. Haematol. 96, 584–593.
Thomas, W. D. and Hersey, P (1998) TNF-related apoptosis-inducing ligand (TRAIL) induces apoptois in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol. 161, 2195–2200.
Routes, J. M., Ryan, S., Clase, A., et al. (2000) Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165, 4522–4527.
Meager, A. (1987) Quantification of interferons by anti-viral assays and their standardization, in Lymphokines and Interferons—A Practical Approach (Clemens, M. J., Morris, A. G., and Gearing, A. J. H., eds.), IRL, Oxford, pp. 129–147.
Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.
Buttke, T. M., McCubrey, J. A., and Owen, T. C. (1993) Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods 157, 233–240.
Gaines Das, R. E. and Meager, A. (1995) Evaluation of assay designs for assays using microtitre plates: results of a study of in vitro bioassays and immunoassays for tumour necrosis factor (TNF). Biologicals 23, 285–297.
Meager, A. (1998) Biological standardization of interferons and other cytokines, in Bioseparation and Bioprocessing, Vol. II. (Subramanian, G., ed.), Wiley-VCH, Weinheim, pp. 255–274.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Meager, A. (2004). Assays for Cytotoxicity. In: De Ley, M. (eds) Cytokine Protocols. Methods in Molecular Biology, vol 249. Humana Press. https://doi.org/10.1385/1-59259-667-3:135
Download citation
DOI: https://doi.org/10.1385/1-59259-667-3:135
Publisher Name: Humana Press
Print ISBN: 978-0-89603-948-3
Online ISBN: 978-1-59259-667-6
eBook Packages: Springer Protocols